Clinical Trial Update: A Clinical Study of TQC2731 Injection in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of TQC2731 injection for moderate to severe Chronic Obstructive Pulmonary Disease is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• TQC2731

Snippet

Sponsor: Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. | Conditions: Chronic Obstructive Pulmonary Disease | Phase 2 | Status: ACTIVE_NOT_RECRUITING